The refreshed microsite at AccessAgenda.NACDS.org supports NACDS' advocacy campaigns on priority topics.
Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues
Many recent NACDS RxIMPACT pharmacy tours have been directly with members of Congress themselves—68 percent so far this year.
Industry collaboration; advancing opioid abuse prevention; and fighting phantom “DIR” fees stood among key themes at Sunday Business Program.
The total number of NACDS RxIMPACT 2019 in-district events to promote DIR relief priorities now stands at 72—and counting.
“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”
NACDS Board of Directors members met with key members of Congress in Washington, D.C., to convey the urgent need for DIR fee relief.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
NACDS: “Dire” problem for patients, pharmacies must be fixed in drug-pricing bill
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
